Generex Investor Conference Call Recording Now Available Online Detailing 1:1 Stock Dividend, Merger for NuGenerex Immuno-Oncology and Go Forward Plans
June 24, 2019 08:30 ET
|
Generex Biotechnology Corporation
MIRAMAR, Fla., June 24, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) today announced the audio recording of...
Generex Announces That the Pool Shares for the Benefit of Generex Will Be Retired and Put Back into the Corporate Treasury Following Payment of the 1:1 Dividend
June 21, 2019 08:30 ET
|
Generex Biotechnology Corporation
MIRAMAR, Fla., June 21, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) today announced that the “Pool” shares...
Generex Declares 1:1 Stock Dividend
June 20, 2019 09:00 ET
|
Generex Biotechnology Corporation
MIRAMAR, Fla., June 20, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) is pleased to announce that the company...
Reminder: Investor Conference Call Friday June 21st, 2019
June 17, 2019 09:00 ET
|
Generex Biotechnology Corporation
Management to Provide Update on Initiatives & Strategic PlansCall-in Details MIRAMAR, Fla., June 17, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT)...
Generex Provides Update to Pending 1:1 Stock Dividend
June 07, 2019 09:30 ET
|
Generex Biotechnology Corporation
MIRAMAR, Fla., June 07, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote), in response to the large volume of...
Generex Biotechnology CEO Joe Moscato To Present at H.C. Wainwright Healthcare Conference
June 04, 2019 09:00 ET
|
Generex Biotechnology Corporation
H.C. WAINWRIGHT 21st ANNUAL GLOBAL INVESTMENT CONFERENCEThe Lotte New York Palace Hotel, New York, NY September 8 – 10, 2019 MIRAMAR, Fla., June 04, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology...
Generex Biotechnology Announces Date for Rescheduled May 15th Investor Conference Call to Present Organizational Roadmap & Update on Investor Dividend, Product Launch, New Acquisitions, Financing, Expansion Initiatives & Strategic Plans
June 03, 2019 09:00 ET
|
Generex Biotechnology Corporation
Generex shareholder dividend follow-upLaunch of FDA Cleared Excellagen® for Wound Management by subsidiary Olaregen TherapeutixUpdate on NuGenerex Immuno-Oncology Spin-out and dividend sharesPending...
Generex Biotechnology Announces Share Dividend & Strategic Plans
May 31, 2019 09:45 ET
|
Generex Biotechnology Corporation
MIRAMAR, Fla., May 31, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) is pleased to announce that the company...
Generex Biotechnology Announces that its Subsidiary Olaregen Therapeutix Launches Excellagen at The Symposium on Advanced Wound Care (SAWC) in San Antonio, TX
May 16, 2019 09:00 ET
|
Generex Biotechnology Corporation
MIRAMAR, Fla., May 16, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) is pleased to announce that its...
Generex Biotechnology Announces Postponement of Its May 15th Investor Conference Call
May 15, 2019 09:00 ET
|
Generex Biotechnology Corporation
MIRAMAR, Fla., May 15, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) today announced that the company has...